https://www.selleckchem.com/pr....oducts/fluorofurimaz
To evaluate the long-term efficacy of three currently available drug coated balloons (DC for the treatment of de-novo coronary lesions. This was a retrospective analysis of prospectively collected data from the Swedish Coronary Angiography and Angioplasty Registry. Between 2009 and 2017, three currently available DCB brands used in the treatment of de novo lesions were included. Outcomes were clinically driven restenosis and target lesion thrombosis (TLT) (per device) and major adverse cardiac events (MACE) including death, m
Like
Comment
Share
